World's Best Scientists 2026 revealed!
Yasushi Yatabe

Yasushi Yatabe

Award Badge
Medicine
Japan
2023

D-Index & Metrics

Medicine

D-Index
124
Citations
80635
World Ranking
3158
National Ranking
56

Research.com Recognitions

  • 2023 - Research.com Medicine in Japan Leader Award

Overview

Yasushi Yatabe is affiliated with Nagoya University in Japan and has a research focus primarily within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans several subfields including Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology, and Radiology, Nuclear Medicine and Imaging.

The scientist's research topics encompass a range of areas related to lung cancer and cancer biology. Key main topics of their work include:

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Colorectal Cancer Treatments and Studies

Frequent collaborators with Yasushi Yatabe include Shun-ichi Watanabe, Hidehito Horinouchi, Yukihiro Yoshida, Kouya Shiraishi, and Yuichiro Ohe. These coauthors have contributed to multiple joint publications, with collaboration counts ranging from 31 to 57 papers each.

The scientist has published extensively in several academic journals. Their most common publication venues are:

  • Journal of Thoracic Oncology (46 publications)
  • Journal of Clinical Oncology (13 publications)
  • Pathology International (12 publications)
  • Lung Cancer (10 publications)
  • The American Journal of Surgical Pathology (9 publications)

Among their recent published papers are:

  • The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015, 2021, Journal of Thoracic Oncology
  • Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments, 2022, Cancer Cell
  • A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee, 2020, Journal of Thoracic Oncology
  • IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy, 2020, Journal of Thoracic Oncology
  • The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee, 2020, Journal of Thoracic Oncology

Best Publications

  • International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    William D Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G Nicholson

  • The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification

    William D. Travis;Elisabeth Brambilla;Andrew G. Nicholson;Yasushi Yatabe

  • Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

    Tetsuya Mitsudomi;Satoshi Morita;Yasushi Yatabe;Shunichi Negoro

  • Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

    Junichi Takamizawa;Hiroyuki Konishi;Kiyoshi Yanagisawa;Shuta Tomida

  • Comprehensive genomic profiles of small cell lung cancer

    Julie George;Jing Shan Lim;Se Jin Jang;Yupeng Cun

  • A Polycistronic MicroRNA Cluster, miR-17-92, Is Overexpressed in Human Lung Cancers and Enhances Cell Proliferation

    Yoji Hayashita;Hirotaka Osada;Yoshio Tatematsu;Hideki Yamada

  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    Neal I. Lindeman;Philip T. Cagle;Dara L. Aisner;Maria E. Arcila

  • Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer Biological and Clinical Implications

    Takayuki Kosaka;Yasushi Yatabe;Hideki Endoh;Hiroyuki Kuwano

  • EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors

    Young Lim Choi;Manabu Soda;Yoshihiro Yamashita;Toshihide Ueno

  • Increased Expression of Cyclooxygenase 2 Occurs Frequently in Human Lung Cancers, Specifically in Adenocarcinomas

    Toyoaki Hida;Yasushi Yatabe;Hiroyuki Achiwa;Hideki Muramatsu

  • Mutations of the Epidermal Growth Factor Receptor Gene Predict Prolonged Survival After Gefitinib Treatment in Patients With Non–Small-Cell Lung Cancer With Postoperative Recurrence

    Tetsuya Mitsudomi;Takayuki Kosaka;Hideki Endoh;Yoshitsugu Horio

  • The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015.

    Andrew G. Nicholson;Ming S. Tsao;Mary Beth Beasley;Alain C. Borczuk

  • Reduced expression of Dicer associated with poor prognosis in lung cancer patients.

    Yoko Karube;Hisaaki Tanaka;Hisaaki Tanaka;Hirotaka Osada;Shuta Tomida

  • Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

    Seiji Yano;Wei Wang;Qi Li;Kunio Matsumoto

  • Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib

    Takayuki Kosaka;Yasushi Yatabe;Hideki Endoh;Kimihide Yoshida

  • The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

    William D. Travis;Hisao Asamura;Alexander A. Bankier;Mary Beth Beasley

  • Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer.

    Tetsuya Mitsudomi;Yasushi Yatabe

  • Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer

    Tetsuya Mitsudomi;Yasushi Yatabe

  • International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.

    William D. Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G. Nicholson

  • PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.

    Ming Sound Tsao;Keith M. Kerr;Mark Kockx;Mary Beth Beasley

Frequent Co-Authors

Tetsuya Mitsudomi
Tetsuya Mitsudomi Kindai University
Keitaro Matsuo
Keitaro Matsuo Nagoya University
Takashi Takahashi
Takashi Takahashi Nagoya University
Shigeo Nakamura
Shigeo Nakamura Nagoya University
Keith M. Kerr
Keith M. Kerr Aberdeen Royal Infirmary
Kei Muro
Kei Muro National Cancer Research Institute, UK
Ming-Sound Tsao
Ming-Sound Tsao Princess Margaret Cancer Centre
Masao Seto
Masao Seto Kurume University
William D. Travis
William D. Travis Memorial Sloan Kettering Cancer Center
Andrew G. Nicholson
Andrew G. Nicholson Royal Brompton Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees in the medical field can open doors to diverse career paths, whether you're a recent high school graduate or a working professional aiming to upskill. There are a variety of online options in healthcare that offer both flexibility and affordability.

One popular pathway is in medical administration, where medical billing and coding cost programs allow students to earn credentials quickly and prepare for entry into administrative roles. For those interested in patient care, affordable online nursing programs make it possible to start a nursing career without the financial burden of traditional on-campus learning.

Advanced practice roles are also accessible online. Aspiring nurse practitioners can consider enrolling in the cheapest online fnp program for specialized, graduate-level training. For nurses aiming at leadership or academic careers, earning an online nursing doctorate represents the highest educational achievement in the field, often at a more manageable cost than in-person alternatives.

By choosing online health degrees, students can balance professional responsibilities with study, save on tuition, and build rewarding careers in the ever-growing healthcare sector.

Best Scientists Citing Yasushi Yatabe

Trending Scientists

Recently Published Articles